<DOC>
	<DOCNO>NCT02398708</DOCNO>
	<brief_summary>The purpose study examine gut bacteria , level peripheral blood inflammation marker , symptom patient without chronic graft-versus-host disease ( cGVHD ) follow allogeneic hematopoietic stem cell transplant ( allo-HSCT ) . The hypothesis individual cGVHD low level microbial diversity , high level inflammatory metabolite stool peripheral measure , high level symptoms individual without cGVHD .</brief_summary>
	<brief_title>Comparison Gut Microbiota , Inflammation Symptoms Following Allogeneic HSCT</brief_title>
	<detailed_description>This study recruit 40 ( 20 cGVHD 20 without cGVHD ) adults Bone Marrow Transplant Program University Florida Health Shands Cancer Hospital . After sign informed consent , participant fill questionnaire blood sample collect vein arm . Participants give stool collection kit instruction return sample via mail . Data collect securely stored system use cancer center research . Descriptive statistic use report individual , clinical factor , symptom . Knowledge gain study provide preliminary data future longitudinal study examine biological pathway development , severity and/or duration cGVHD symptom outcomes individual follow allo-HSCT impact quality life .</detailed_description>
	<mesh_term>Graft v Host Disease</mesh_term>
	<criteria>Group 1 : Adults ( &gt; 18 year age ) within 3 month 3 year receive allogeneic hematopoietic stem cell transplant ( alloHSCT ) diagnose cGVHD ; Group 2 : Adults ( &gt; 18 year age ) within 3 month 3 year receive alloHSCT without diagnosis cGVHD ; All participant must able willing complete paper pencil questionnaire , provide blood stool sample , able give inform consent . Diagnosed significant secondary inflammatory disease multiple sclerosis , Crohn 's disease , rheumatoid arthritis secondary cancer ; History major psychological disorder require psychotropic medication initiation antidepressant within 30 day enrollment ; Incarcerated pregnant ; Any condition opinion principal investigator ( PI ) may compromise study participation eligible participation study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Hematopoietic Stem Cell Transplantation</keyword>
	<keyword>Graft versus Host Disease</keyword>
</DOC>